Literature DB >> 17513177

Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients.

Eduardo Bonilla1, Lisa Francis, Fatme Allam, Meribeth Ogrinc, Hom Neupane, Paul E Phillips, Andras Perl.   

Abstract

Antinuclear antibodies (ANA) are a hallmark of systemic lupus erythematosus (SLE) and one of its key diagnostic criteria. Recently, new technologies based on antibody binding to fluorescence beads (FB) have been widely employed for ANA screening. We conducted a formal study in 385 consecutive patients who underwent both traditional immunofluorescence (IF) and FB testing and evaluated each patient for the diagnosis of SLE. The distribution of ANA test results was significantly different (chi(2)=73.12; p<0.0001) due to a marked discordance of double-negative and double-positive results. The concordance of the FB-negative and IF-negative test results was 240/256 (95.6%), while the concordance of double-positive results was 54/129 (41.9%). The sensitivity of IF was markedly higher (48/53; 90.6%) than that of the FB (26/53; 49.1%; p<0.0001) for the diagnosis of SLE. IF had a lower specificity (76%) than FB (87%; p=0.0002). The present data show that the IF assay has superior sensitivity for detection of ANA and should continue to be used as the primary screening test for the diagnosis of SLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513177      PMCID: PMC3334847          DOI: 10.1016/j.clim.2007.04.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods.

Authors:  Anne-Marie Rouquette; Chantal Desgruelles; Pascale Laroche
Journal:  Am J Clin Pathol       Date:  2003-11       Impact factor: 2.493

2.  Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays.

Authors:  W Emlen; L O'Neill
Journal:  Arthritis Rheum       Date:  1997-09

3.  Range of antinuclear antibodies in "healthy" individuals.

Authors:  E M Tan; T E Feltkamp; J S Smolen; B Butcher; R Dawkins; M J Fritzler; T Gordon; J A Hardin; J R Kalden; R G Lahita; R N Maini; J S McDougal; N F Rothfield; R J Smeenk; Y Takasaki; A Wiik; M R Wilson; J A Koziol
Journal:  Arthritis Rheum       Date:  1997-09

4.  Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.

Authors:  O Shovman; B Gilburd; G Zandman-Goddard; A Yehiely; P Langevitz; Y Shoenfeld
Journal:  Autoimmunity       Date:  2005-02       Impact factor: 2.815

5.  Suppression of non-specific binding in serological Luminex assays.

Authors:  Tim Waterboer; Peter Sehr; Michael Pawlita
Journal:  J Immunol Methods       Date:  2005-12-19       Impact factor: 2.303

6.  Presentation of two bone marrow elements; the tart cell and the L.E. cell.

Authors:  M M HARGRAVES; H RICHMOND; R MORTON
Journal:  Proc Staff Meet Mayo Clin       Date:  1948-01-21

7.  Analysis of human sera that are polyreactive in an addressable laser bead immunoassay.

Authors:  Marvin J Fritzler; Fatemeh Behmanesh; Mark L Fritzler
Journal:  Clin Immunol       Date:  2006-04-27       Impact factor: 3.969

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.

Authors:  Artemissia-Phoebe Nifli; George Notas; Marilena Mamoulaki; Maria Niniraki; Vaso Ampartzaki; Panayiotis A Theodoropoulos; Mark J Kopnitsky; Elias Castanas
Journal:  J Immunol Methods       Date:  2006-03-03       Impact factor: 2.303

10.  Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.

Authors:  Charlotte Dahle; Thomas Skogh; A K Aberg; A Jalal; P Olcén
Journal:  J Autoimmun       Date:  2004-05       Impact factor: 7.094

View more
  10 in total

1.  Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy.

Authors:  Scott Brian Minchenberg; Geeta Chaparala; Zachary Oaks; Katalin Banki; Andras Perl
Journal:  Clin Immunol       Date:  2018-07-17       Impact factor: 3.969

2.  Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus.

Authors:  Gabriela Schmajuk; Bimba F Hoyer; Martin Aringer; Sindhu R Johnson; David I Daikh; Thomas Dörner
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-11       Impact factor: 4.794

3.  Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.

Authors:  Yuxin Liu; Jianghong Yu; Zachary Oaks; Ivan Marchena-Mendez; Lisa Francis; Eduardo Bonilla; Phillip Aleksiejuk; Jessica Patel; Katalin Banki; Steve K Landas; Andras Perl
Journal:  Clin Immunol       Date:  2015-07-06       Impact factor: 3.969

4.  How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.

Authors:  R Hira-Kazal; P Shea-Simonds; J L Peacock; J Maher
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

Review 5.  Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases.

Authors:  Minoru Satoh; Monica Vázquez-Del Mercado; Edward K L Chan
Journal:  Mod Rheumatol       Date:  2009-03-10       Impact factor: 3.023

6.  Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory.

Authors:  Renato Tozzoli; Antonio Antico; Brunetta Porcelli; Danila Bassetti
Journal:  Auto Immun Highlights       Date:  2012-07-13

7.  Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.

Authors:  Seri Jeong; Heeyoung Yang; Hyunyong Hwang
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

8.  Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells.

Authors:  Jörn Voigt; Christopher Krause; Edda Rohwäder; Sandra Saschenbrecker; Melanie Hahn; Maick Danckwardt; Christian Feirer; Konstantin Ens; Kai Fechner; Erhardt Barth; Thomas Martinetz; Winfried Stöcker
Journal:  Clin Dev Immunol       Date:  2012-11-11

Review 9.  New platform technology for comprehensive serological diagnostics of autoimmune diseases.

Authors:  Annika Willitzki; Rico Hiemann; Vanessa Peters; Ulrich Sack; Peter Schierack; Stefan Rödiger; Ursula Anderer; Karsten Conrad; Dimitrios P Bogdanos; Dirk Reinhold; Dirk Roggenbuck
Journal:  Clin Dev Immunol       Date:  2012-12-19

10.  Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited.

Authors:  Yashwant Kumar; Alka Bhatia; Ranjana Walker Minz
Journal:  Diagn Pathol       Date:  2009-01-02       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.